Barclays’s Accendra Health ACH Stock Holding History

Barclays’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-106,300	Closed	-$2.95M	–	5180
2024 Q1	$2.95M	Buy	+106,300	New	+$2.36M	﹤0.01%	2248

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barclays's ACH Position: Q1 2026 in Review

Barclays reduced its Accendra Health (ACH) stake by 87% in Q1 2026, selling an estimated $236K and leaving 15,278 shares worth $34.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4434.

Barclays first reported a position in ACH in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.14M in Q1 2021. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

Barclays held 15,278 shares of Accendra Health worth $34.8K as of Q1 2026.
Barclays sold 102,325 Accendra Health shares in Q1 2026, an estimated $236K.
Accendra Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4434 holding.
Barclays first reported a position in Accendra Health in Q2 2013 and has held it in 52 quarters since.
Barclays's Accendra Health position peaked at $6.14M in Q1 2021.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.